rs121918289
Variant summary
Our verdict is Pathogenic. Variant got 14 ACMG points: 14P and 0B. PM2PP3_StrongPP5_Very_Strong
The NM_001363591.2(BEST1):c.-63G>A variant causes a 5 prime UTR premature start codon gain change involving the alteration of a conserved nucleotide. The variant was absent in control chromosomes in GnomAD project. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Pathogenic (★★).
Frequency
Consequence
NM_001363591.2 5_prime_UTR_premature_start_codon_gain
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Pathogenic. Variant got 14 ACMG points.
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes Cov.: 33
GnomAD4 exome Data not reliable, filtered out with message: AC0 AF: 0.00 AC: 0AN: 1388074Hom.: 0 Cov.: 38 AF XY: 0.00 AC XY: 0AN XY: 684784
GnomAD4 genome Cov.: 33
ClinVar
Submissions by phenotype
Retinal dystrophy Pathogenic:2
- -
- -
Autosomal dominant vitreoretinochoroidopathy Pathogenic:1
- -
not provided Pathogenic:1
This sequence change replaces valine, which is neutral and non-polar, with methionine, which is neutral and non-polar, at codon 86 of the BEST1 protein (p.Val86Met). This variant is not present in population databases (gnomAD no frequency). This missense change has been observed in individuals with autosomal dominant vitreoretinochoroidopathy (PMID: 15452077, 21072067, 26771239). It has also been observed to segregate with disease in related individuals. ClinVar contains an entry for this variant (Variation ID: 2744). Invitae Evidence Modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) indicates that this missense variant is expected to disrupt BEST1 protein function with a positive predictive value of 95%. Experimental studies are conflicting or provide insufficient evidence to determine the effect of this variant on BEST1 function (PMID: 15452077). This variant disrupts the p.Val86 amino acid residue in BEST1. Other variant(s) that disrupt this residue have been determined to be pathogenic (internal data). This suggests that this residue is clinically significant, and that variants that disrupt this residue are likely to be disease-causing. For these reasons, this variant has been classified as Pathogenic. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at